1. Downregulation of nucleoporin 88 and 214 induced by oridonin may protect OCIM2 acute erythroleukemia cells from apoptosis through regulation of nucleocytoplasmic transport of NF-κB
   SHA YI et al, 2012 CrossRef
2. Oridonin exerts protective effects against hydrogen peroxide‑induced damage by altering microRNA expression profiles in human dermal fibroblasts.
   Eun-Jin Lee et al, 2013, Int. J. Mol. Med. CrossRef
3. Oridonin protects HaCaT keratinocytes against hydrogen peroxide-induced oxidative stress by altering microRNA expression
   SEUNGHEE BAE et al, 2014 CrossRef
4. Oridonin promotes G2/M arrest in A549 cells by facilitating ATM activation
   Mingxing Zheng et al, 2017 CrossRef
5. Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells
   QIU-XIANG WU et al, 2016 CrossRef
6. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression
   SHIHONG MA et al, 2016 CrossRef
7. Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK
   CHUN-MEI REN et al, 2016 CrossRef
8. New Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of Autophagy
   Betty Law et al, 2016, Molecules CrossRef
9. Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection
   Jimin Xu et al, 2018, Molecules CrossRef
10. Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update
    Junmin Zhang et al, 2018, Med Res Rev CrossRef
11. Does Nrf2 Contribute to p53-Mediated Control of Cell Survival and Death?
    Weimin Chen et al, 2012, Antioxidants & Redox Signaling CrossRef
12. Synergistic antitumor activity of oridonin and valproic acid on HL-60 leukemia cells
    Wei Li et al, 2018, J Cell Biochem CrossRef
13. Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia
    Roberto Ciarcia et al, 2016, J. Cell. Physiol. CrossRef
14. Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro.
    Fei-Fei Li et al, 2014, Acta Pharmacol. Sin. CrossRef
15. Apoptotic effects of hsian‐tsao ( Mesona procumbens Hemsley) on hepatic stellate cells mediated by reactive oxygen species and ERK, JNK, and caspase‐3 pathways
    Yung‐Hsiang Yeh et al, 2019, Food Sci Nutr CrossRef
16. Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling
    Shixin Xia et al, 2017, Saudi Pharmaceutical Journal CrossRef
17. Synergistic Apoptosis of CML Cells by Buthionine Sulfoximine and Hydroxychavicol Correlates with Activation of AIF and GSH-ROS-JNK-ERK-iNOS Pathway
    Avik Acharya Chowdhury et al, 2013, PLoS ONE CrossRef
18. Oridonin induces Mdm2-p60 to promote p53-mediated apoptosis and cell cycle arrest in neuroblastoma.
    Han-Qing Zhu et al, 2019, Cancer Med CrossRef
19. Powerful tumor cell growth-inhibiting activity of a synthetic derivative of atractyligenin: Involvement of PI3K/Akt pathway and thioredoxin system
    Roberta Cotugno et al, 2014, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
20. Constructive innovation of approaching bicyclo[3.2.1]octane in ent-kauranoids
    Lili Zhu et al, 2015, Tetrahedron Letters CrossRef
21. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects
    Jie Yang et al, 2015, Biomedicine & Pharmacotherapy CrossRef
22. Molecular Insight in the Multifunctional Effects of Oridonin
    Brice Ayissi Owona et al, 2015, Drugs R D CrossRef
23. Qualitative and Quantitative Analysis of ROS-Mediated Oridonin-Induced Oesophageal Cancer KYSE-150 Cell Apoptosis by Atomic Force Microscopy
    Jiang Pi et al, 2015, PLoS ONE CrossRef
24. Natural products against hematological malignancies and identification of their targets
    Ying Xu et al, 2015, Sci. China Life Sci. CrossRef
25. Oridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells
    Yuan Zhang et al, 2017, Saudi Journal of Biological Sciences CrossRef
26. null
    C. Ding et al, 2017 CrossRef
27. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.
    Hua Luo et al, 2019, Chin Med CrossRef
28. Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia
    Xu Hu et al, 2020, MRMC CrossRef
29. Oridonin induces apoptosis in HGC‑27 cells by activating the JNK signaling pathway
    Dong‑Lin Ren et al, 2019, Oncol Lett CrossRef
30. Oridonin induces ferroptosis by inhibiting gamma‐glutamyl cycle in TE1 cells
    Junhong Zhang et al, 2020, Phytotherapy Research CrossRef
31. Natural Molecules Targeting Thioredoxin System and Their Therapeutic Potentials
    Junmin Zhang et al, 2020, Antioxidants & Redox Signaling CrossRef
32. Terpenoids’ anti-cancer effects: focus on autophagy
    Chirine El-Baba et al, 2021, Apoptosis CrossRef
33. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy.
    Boyi Niu et al, 2021, Biomaterials CrossRef
34. Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review
    Sajad Fakhri et al, 2021, Pharmacological Research CrossRef
35. Oridonin Dose-Dependently Modulates the Cell Senescence and Apoptosis of Gastric Cancer Cells
    Yiping Wang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
36. Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells
    Shusuke Yasuda et al, 2022, Biochemical and Biophysical Research Communications CrossRef
37. Sesquiterpene Lactones Potentiate Olaparib-Induced DNA Damage in p53 Wildtype Cancer Cells
    Hugh C. Osborne et al, 2022, IJMS CrossRef
38. Natural compounds as inhibitors of thioredoxin reductase (TrxR1)
    E. G. Chupakhin et al, 2022, Russ Chem Bull CrossRef
39. Oridonin Induces Oxidative Stress-mediated Cancer Cells Apoptosis via Targeting Thioredoxin Reductase
    Dongzhu Duan et al, 2022, CPB CrossRef
40. Protection Impacts of Coix lachryma-jobi L. Seed Lactobacillus reuteri Fermentation Broth on Hydrogen Peroxide-Induced Oxidative Stress in Human Skin Fibroblasts
    Jiaxuan Fang et al, 2022, Applied Sciences CrossRef
41. Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
    Solveigh C. Koeberle et al, 2023, Medicinal Research Reviews CrossRef
42. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases.
    Chi Teng Vong et al, 2021, Drug Discov Today CrossRef
43. Targeting Myc-driven stress addiction in colorectal cancer
    Haris Saeed et al, 2023, Drug Resistance Updates CrossRef
44. Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications
    Jianghua Ding et al, 2023, Materials Today Bio CrossRef
45. Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review
    Muhammad Asif Ali et al, 2024, Food Science & Nutrition CrossRef
46. Oxidative Stress and Chronic Myeloid Leukemia: A Balance between ROS-Mediated Pro- and Anti-Apoptotic Effects of Tyrosine Kinase Inhibitors
    Alessandro Allegra et al, 2024, Antioxidants CrossRef
47. Thioredoxin system in colorectal cancer: Its role in carcinogenesis, disease progression, and response to treatment
    Nurul Akmaryanti Abdullah et al, 2024, Life Sciences CrossRef
48. Enhancing cancer therapy: advanced nanovehicle delivery systems for oridonin
    Yilin Su et al, 2024, Front. Pharmacol. CrossRef
49. Oxidative stress and cellular senescence: Roles in tumor progression and therapeutic opportunities
    Ping Jin et al, 2024, MedComm – Oncology CrossRef